231 related articles for article (PubMed ID: 2553899)
41. Localization of angiotensin converting enzyme in rat heart.
Yamada H; Fabris B; Allen AM; Jackson B; Johnston CI; Mendelsohn AO
Circ Res; 1991 Jan; 68(1):141-9. PubMed ID: 1845851
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of brain angiotensin-converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats.
Tan J; Wang JM; Leenen FH
Am J Hypertens; 2005 Feb; 18(2 Pt 1):158-64. PubMed ID: 15752941
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics of angiotensin converting enzyme inhibition in tissues following oral lisinopril: studies in the rat using quantitative radioinhibitor binding.
Jackson B; Cubela R; Sakaguchi K; Johnston CI
Clin Exp Pharmacol Physiol; 1987 Apr; 14(4):343-7. PubMed ID: 2822313
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography.
Sakaguchi K; Chai SY; Jackson B; Johnston CI; Mendelsohn FA
Hypertension; 1988 Mar; 11(3):230-8. PubMed ID: 2832327
[TBL] [Abstract][Full Text] [Related]
45. Relative inhibitory potency and plasma drug levels of angiotensin converting enzyme inhibitors in the rat.
Johnston CI; Cubela R; Jackson B
Clin Exp Pharmacol Physiol; 1988 Feb; 15(2):123-9. PubMed ID: 2856050
[TBL] [Abstract][Full Text] [Related]
46. Effect of acute and chronic administration of ceronapril on angiotensin converting enzyme in plasma, kidney, lung, brain regions and cerebrospinal fluid of rats.
Chen BZ; Mendelsohn FA
Neuropharmacology; 1992 Sep; 31(9):929-35. PubMed ID: 1331844
[TBL] [Abstract][Full Text] [Related]
47. Presence of angiotensin converting enzyme in the adventitia of large blood vessels.
Rogerson FM; Chai SY; Schlawe I; Murray WK; Marley PD; Mendelsohn FA
J Hypertens; 1992 Jul; 10(7):615-20. PubMed ID: 1321187
[TBL] [Abstract][Full Text] [Related]
48. Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme.
Perich RB; Jackson B; Johnston CI
Eur J Pharmacol; 1994 Feb; 266(3):201-11. PubMed ID: 8174603
[TBL] [Abstract][Full Text] [Related]
49. Acute and long-term dose-response study of quinapril on hormonal profile and tissue angiotensin-converting enzyme in Wistar rats.
Schaison FH; Fernando Ramirez-Gil J; Ciferri S; Bernard M; Baudin B; Mougenot N; Carayon A; Lechat P
J Cardiovasc Pharmacol; 1996 Jul; 28(1):11-8. PubMed ID: 8797130
[TBL] [Abstract][Full Text] [Related]
50. Angiotensin-converting enzyme inhibitors: measurement of relative inhibitory potency and serum drug levels by radioinhibitor binding displacement assay.
Jackson B; Cubela R; Johnston CI
J Cardiovasc Pharmacol; 1987 Jun; 9(6):699-704. PubMed ID: 2442537
[TBL] [Abstract][Full Text] [Related]
51. [Relations between pharmacokinetics and effectiveness of ACE inhibitors].
Rettig R; Gohlke P; Unger T
Z Kardiol; 1991; 80 Suppl 2():16-20. PubMed ID: 2024539
[TBL] [Abstract][Full Text] [Related]
52. [Studies on angiotensin I converting enzyme (ACE): inhibitory effect of imidapril, a novel ACE inhibitor (II). Inhibition of various tissue ACEs ex vivo].
Hashimoto Y; Kubo M; Sugaya T; Minobe S; Watanabe T; Yamamura M; Matsuoka Y
Nihon Yakurigaku Zasshi; 1994 Jul; 104(1):51-61. PubMed ID: 8076891
[TBL] [Abstract][Full Text] [Related]
53. Differential angiotensin-converting enzyme inhibition in brain after oral administration of perindopril demonstrated by quantitative in vitro autoradiography.
Sakaguchi K; Chai SY; Jackson B; Johnston CI; Mendelsohn FA
Neuroendocrinology; 1988 Sep; 48(3):223-8. PubMed ID: 2847068
[TBL] [Abstract][Full Text] [Related]
54. A pharmacodynamic and pharmacokinetic comparison of intravenous quinaprilat and oral quinapril.
Breslin E; Posvar E; Neub M; Trenk D; Jahnchen E
J Clin Pharmacol; 1996 May; 36(5):414-21. PubMed ID: 8739020
[TBL] [Abstract][Full Text] [Related]
55. Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography: tissue selective induction after chronic lisinopril treatment.
Kohzuki M; Johnston CI; Chai SY; Jackson B; Perich R; Paxton D; Mendelsohn FA
J Hypertens; 1991 Jul; 9(7):579-87. PubMed ID: 1653792
[TBL] [Abstract][Full Text] [Related]
56. A novel angiotensin analog with subnanomolar affinity for angiotensin-converting enzyme.
Krebs LT; Hanesworth JM; Sardinia MF; Speth RC; Wright JW; Harding JW
J Pharmacol Exp Ther; 2000 Apr; 293(1):260-7. PubMed ID: 10734177
[TBL] [Abstract][Full Text] [Related]
57. The role of enzyme and substrate concentration in the evaluation of serum angiotensin converting enzyme (ACE) inhibition by enalaprilat in vitro.
Weisser K; Schloos J
Biochem Pharmacol; 1991 Oct; 42(9):1729-37. PubMed ID: 1656995
[TBL] [Abstract][Full Text] [Related]
58. Chronic ACE inhibition by quinapril modulates central vasopressinergic system.
Muders F; Elsner D; Jandeleit K; Bahner U; Kromer EP; Kirst I; Riegger GA; Palkovits M
Cardiovasc Res; 1997 Jun; 34(3):575-81. PubMed ID: 9231041
[TBL] [Abstract][Full Text] [Related]
59. Modulation of proteolytic activity in tissues following chronic inhibition of angiotensin-converting enzyme.
Juillerat-Jeanneret L
Biochem Pharmacol; 1993 Apr; 45(7):1447-54. PubMed ID: 8097091
[TBL] [Abstract][Full Text] [Related]
60. Differential inhibition of plasma versus tissue ACE by utibapril: biochemical and functional evidence for inhibition of vascular ACE activity.
Buikema H; Pinto YM; van Geel PP; Rooks G; de Langen CD; de Graeff PA; van Gilst WH
J Cardiovasc Pharmacol; 1997 May; 29(5):684-91. PubMed ID: 9213213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
